scPharmaceuticals Inc.
SCPHDelisted Oct 7, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001604950
scPharmaceuticals Inc. was delisted on Oct 7, 2025; its insiders filed their last Form 4 on Oct 7, 2025; 110 institutions reported holding it in 13F filings for Q3 2025, worth $232.3M in total; no superinvestor held it.
13F holders, Q1 2022
Institutional positions in scPharmaceuticals Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- +4 vs. Q4 2021
- Shares held
- 15.9M
- −53.1K (−0.3%) vs. Q4 2021
- Total value
- $90.1M
- +$10.1M (+12.7%) vs. Q4 2021
- New holders
- 6
- 8 more added
- Sold out
- 2
- 14 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SCPH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 110 | $232.3M |
| Q2 2025 | 98 | $145.7M |
| Q1 2025 | 88 | $98.7M |
| Q4 2024 | 86 | $140.8M |
| Q3 2024 | 95 | $169.8M |
| Q2 2024 | 77 | $121.0M |
| Q1 2024 | 76 | $134.2M |
| Q4 2023 | 81 | $175.4M |
| Q3 2023 | 73 | $213.1M |
| Q2 2023 | 81 | $290.8M |
| Q1 2023 | 63 | $223.2M |
| Q4 2022 | 59 | $153.5M |
| Q3 2022 | 40 | $91.3M |
| Q2 2022 | 38 | $75.9M |
| Q1 2022 | 37 | $90.1M |
| Q4 2021 | 33 | $80.0M |
| Q3 2021 | 31 | $107.9M |
| Q2 2021 | 38 | $97.9M |
| Q1 2021 | 46 | $114.1M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding scPharmaceuticals Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 4,797,148 | $27.2M | 0.44% | 00.0% | Unchanged |
| 5AM Venture Management, LLC | 3,831,474 | $21.8M | 4.75% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 2,658,583 | $15.1M | 0.33% | −33,187−1.2% | Reduced |
| AIGH Capital Management LLC | 1,396,724 | $7.93M | 2.88% | +23,600+1.7% | Added |
| Ikarian Capital, LLC | 970,098 | $5.51M | 1.68% | +68,736+7.6% | Added |
| Vanguard Group Inc | 616,558 | $3.50M | 0.00% | 00.0% | Unchanged |
| Worth Venture Partners, LLC | 348,425 | $1.98M | 0.93% | +15,778+4.7% | Added |
| Renaissance Technologies LLC | 186,086 | $1.06M | 0.00% | −2,900−1.5% | Reduced |
| Belvedere Trading LLC | 160,882 | $822.0K | 0.58% | +160,882 | New |
| Bridgeway Capital Management, LLC | 132,200 | $751.0K | 0.01% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 103,534 | $588.0K | 0.00% | +6,787+7.0% | Added |
| Boothbay Fund Management, LLC | 86,635 | $492.0K | 0.02% | 00.0% | Unchanged |
| Morgan Stanley | 86,585 | $492.0K | 0.00% | +11,750+15.7% | Added |
| Geode Capital Management, LLC | 69,252 | $393.0K | 0.00% | −1,957−2.7% | Reduced |
| J. Goldman & Co LP | 67,500 | $383.0K | 0.03% | −302,591−81.8% | Reduced |
| BlackRock Inc. | 57,883 | $329.0K | 0.00% | −1,602−2.7% | Reduced |
| Northern Trust Corp | 48,908 | $278.0K | 0.00% | −802−1.6% | Reduced |
| Susquehanna International Group, LLP | 40,689 | $231.0K | 0.00% | +40,689 | New |
| Zacks Investment Management | 36,989 | $210.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 34,603 | $196.0K | 0.00% | −40−0.1% | Reduced |
| Citadel Advisors LLC | 31,494 | $179.0K | 0.00% | +31,494 | New |
| Millennium Management LLC | 24,771 | $141.0K | 0.00% | −8,567−25.7% | Reduced |
| Simplex Trading, LLC | 23,156 | $131.0K | 0.00% | +22,617+4,196.1% | Added |
| State Street Corp | 15,100 | $86.0K | 0.00% | +1,100+7.9% | Added |
| Thomasville National Bank | 15,000 | $85.0K | 0.01% | 00.0% | Unchanged |
| IPG Investment Advisors LLC | 14,300 | $81.0K | 0.02% | 00.0% | Unchanged |
| Sandy Cove Advisors, LLC | 10,592 | $60.0K | 0.05% | 00.0% | Unchanged |
| Envestnet Asset Management Inc | 10,228 | $58.0K | 0.00% | −2,654−20.6% | Reduced |
| Advisor Group Holdings, Inc. | 3,637 | $21.0K | 0.00% | −270−6.9% | Reduced |
| UBS Group AG | 1,000 | $6.00K | 0.00% | −1,253−55.6% | Reduced |
| Bank of America Corp | 1,039 | $6.00K | 0.00% | −133−11.3% | Reduced |
| FMR LLC | 889 | $5.00K | 0.00% | +889 | New |
| Group One Trading, L.P. | 654 | $4.00K | 0.00% | +654 | New |
| Tower Research Capital LLC (TRC) | 100 | $1.00K | 0.00% | +100 | New |
| BNP Paribas Arbitrage, SA | 106 | $602 | 0.00% | −277−72.3% | Reduced |
| Wells Fargo & Company | 61 | $0 | 0.00% | +1+1.7% | Added |
| Royal Bank of Canada | 56 | $0 | 0.00% | −17−23.3% | Reduced |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −81,891−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −14−100.0% | Sold out |